English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Clinical Trials
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
Nov 22, 2021 10:40 HKT
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership
Nov 12, 2021 07:30 HKT
Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies - OCT Webinar
Oct 19, 2021 15:00 HKT
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Oct 19, 2021 15:00 HKT
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
Oct 14, 2021 14:45 HKT
Edison Oncology and Apollomics Announce Treatment of First Patient by EO1001 (APL-122) in a Phase I/IIa Clinical Trial
Oct 01, 2021 10:00 HKT
Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research
Sep 24, 2021 09:00 HKT
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices
Sep 21, 2021 12:00 HKT
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices
Sep 21, 2021 12:00 HKT
Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain
Sep 07, 2021 12:20 HKT
Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia
Aug 26, 2021 13:00 HKT
Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership
Aug 10, 2021 14:00 HKT
Apollomics, Inc. Doses First Patient in a Phase I Clinical Trial of APL-102
Aug 10, 2021 11:53 HKT
ClinTex (CTi) Launches CTi-OEM Blockchain Clinical Trial App
Aug 03, 2021 18:00 HKT
Singapore cord blood bank Cryoviva establishes footprint in the UAE
Jul 27, 2021 08:00 HKT
Premier of South Australia Launches $1.5m Vaccine and Immunobiology State-of-the art Laboratory for APAC Clinical Trials
Jul 14, 2021 17:00 HKT
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia
Jul 09, 2021 20:00 HKT
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth
Jun 28, 2021 14:00 HKT
Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities
Jun 04, 2021 08:00 HKT
Agilex Biolabs and Gyros Protein Technologies Partner for BioAnalysis Zone Webinar on Singlicate Analysis
May 31, 2021 13:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: